Olmesartan improves the insulin resistance and inflammation in patients with hypertension and metabolic syndrome

被引：0
|
作者：
Gonzalez-Albarran, O. [1 ]
Paniagua, A. [1 ]
Lahera, M. [1 ]
Aragon, C. [1 ]
de la Calle, H. [1 ]
Alpanes, M. [1 ]
Rof, J. M. Sancho [1 ]
机构：
[1] Hosp Ramon & Cajal, E-28034 Madrid, Spain
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [21] Metabolic syndrome and hypertension: Pathophysiology and molecular basis of insulin resistance
    Müller-Wieland D.
    Kotzka J.
    Knebel B.
    Krone W.
    Basic Research in Cardiology, 1998, 93 (Suppl 2) : 131 - 134
  • [22] Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited
    da Silva, Alexandre A.
    do Carmo, Jussara M.
    Li, Xuan
    Wang, Zhen
    Mouton, Alan J.
    Hall, John E.
    CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (05) : 671 - 682
  • [23] Metabolic syndrome and hypertension:: pathophysiology and molecular basis of insulin resistance
    Müller-Wieland, D
    Kotzka, J
    Knebel, B
    Krone, W
    BASIC RESEARCH IN CARDIOLOGY, 1998, 93 : 131 - 134
  • [24] Inflammation, hypertension, and the metabolic syndrome
    Grundy, SM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (22): : 3000 - 3002
  • [25] The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C
    Tkachenko, L., I
    Maleev, V. V.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (11) : 24 - 31
  • [26] Modification of NCEP criteria for the metabolic syndrome improves prediction of insulin resistance
    Fonseca, VA
    Kelley, DE
    Henry, RR
    Horton, E
    West, C
    Ghazzi, M
    DIABETES, 2005, 54 : A326 - A326
  • [27] Effects of Olmesartan on insulin sensitivity in non-diabetic hypertensive patients with metabolic syndrome
    Martínez-Martín, FJ
    Macías-Batista, A
    Rodríguez-Rosas, H
    Peiró-Martínez, I
    Soriano, P
    de Pablos-Velasco, PL
    JOURNAL OF HYPERTENSION, 2005, 23 : S103 - S103
  • [28] Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome
    Jahn, Linda A.
    Hartline, Lee
    Liu, Zhenqi
    Barrett, Eugene J.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2022, 322 (02): : E173 - E180
  • [29] METABOLIC EFFECTS DIFFERENT BETA BLOCKERS DEPENDS ON PRESENTS INSULIN RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
    Rekovets, O.
    Sirenko, Y.
    Torbas, O.
    Primak, G.
    Vaschylko, A.
    Pavlyuk, E.
    Savitskiy, S.
    Sidorenko, P.
    Polischuk, S.
    Granich, V.
    Kushnir, S.
    Dobrokhod, A.
    JOURNAL OF HYPERTENSION, 2016, 34 : E305 - E305
  • [30] Treatment with a combination of Olmesartan plus Amlodipine vs. Olmesartan plus Hydrochlorothiazide in hypertensive patients with metabolic syndrome increases insulin sensitivity and adiponectin and reduces inflammation markers
    Martinez-Martin, F. J.
    Macias-Batista, A.
    Rodriguez-Rosas, H.
    Soriano-Perera, P.
    Pedrianes-Martin, P.
    Comi-Diaz, C.
    Peiro-Martinez, I.
    JOURNAL OF HYPERTENSION, 2008, 26 : S331 - S331
12345